More Globe Newswire

View Older Stories View Newer Stories

Apr 28, 2025 05:50PM Amplify Energy Schedules First Quarter 2025 Earnings Release and Conference Call
Apr 28, 2025 05:49PM Farmers & Merchants Bancorp, Inc. Reports 2025 First-Quarter Financial Results
Apr 28, 2025 05:36PM Gannett Fleming TranSystems Changes Name to GFT and Appoints Mike Orth as Chief Executive Officer
Apr 28, 2025 05:31PM Associa Appoints John Reichart as Regional Vice President for the Northeast Region
Apr 28, 2025 05:30PM Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via Mi
Apr 28, 2025 05:26PM CF Energy Announces Financial Results For The Year ended December 31, 2024
Apr 28, 2025 05:24PM Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares
Apr 28, 2025 05:21PM Capital Bancorp, Inc. Announces Strong First Quarter Results and Successful IFH Conversion; Continued Strong Organic Loan and Deposit Growth; NIM and Fee Income Drives Robust Returns
Apr 28, 2025 05:18PM Digital Asset Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
Apr 28, 2025 05:18PM Flexi-View Lending Closes $13.2 Million Acquisition Loan for Multi-Family Property in Milwaukee, WI
Apr 28, 2025 05:13PM PDD Holdings Files Annual Report on Form 20-F for Fiscal Year 2024
Apr 28, 2025 05:10PM SJW Group Announces First Quarter 2025 Financial Results
Apr 28, 2025 05:07PM CVR Energy Reports First Quarter 2025 Results
Apr 28, 2025 05:07PM Real Asset Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
Apr 28, 2025 05:05PM CVR Partners Reports First Quarter 2025 Results
Apr 28, 2025 05:05PM ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Apr 28, 2025 05:04PM VERSES® Announces Closing of US$7.9 Million (C$11.0 Million) Public Offering
Apr 28, 2025 05:02PM AGF Investments Extends Termination Date of AGF Emerging Markets Bond Fund
Apr 28, 2025 05:01PM Brown & Brown, Inc. announces first quarter 2025 results, including total revenues of $1.4 billion, an increase of 11.6%; Organic Revenue growth of 6.5%; diluted net income per share of $1.15; Diluted
Apr 28, 2025 05:01PM Brown & Brown, Inc. announces first quarter 2025 results, including total revenues of $1.4 billion, an increase of 11.6%; Organic Revenue growth of 6.5%; diluted net income per share of $1.15; Dil
Apr 28, 2025 05:00PM AutoZone to Release Third Quarter Fiscal 2025 Earnings May 27, 2025
Apr 28, 2025 05:00PM Finning to report Q1 2025 results on May 12 and hold investor call on May 13, 2025
Apr 28, 2025 05:00PM Report on Financial Results for the Year Ended December 31, 2024
Apr 28, 2025 05:00PM ARCPOINT REPORTS 2024 YEAR END FINANCIAL RESULTS AND ANNOUNCES MANAGEMENT CHANGE
Apr 28, 2025 05:00PM Canacol Energy Ltd. To Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025; Hold Conference Call on Friday, May 9, 2025
Apr 28, 2025 05:00PM ROHM's Latest 2kV SiC MOSFETs Integrated into Semikron Danfoss' Module for SMA's Large-Scale Power Conversion System
Apr 28, 2025 05:00PM ROHM's Latest 2kV SiC MOSFETs Integrated into Semikron Danfoss' Module for SMA's Large-Scale Power Conversion System
Apr 28, 2025 04:53PM TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting
Apr 28, 2025 04:36PM Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
Apr 28, 2025 04:36PM Storytime Bookshop Launches $15,000 Crowdfunding Campaign to Expand Access to Books and Creative Literacy Programs
Apr 28, 2025 04:35PM Arbor Biotechnologies to Present Foundational Data for PH1 and CNS Programs at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Apr 28, 2025 04:35PM Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
Apr 28, 2025 04:31PM Blade Air Mobility Announces Date for First Quarter Ending March 31, 2025 Earnings Release Conference Call
Apr 28, 2025 04:31PM Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
Apr 28, 2025 04:30PM RBB Bancorp Reports First Quarter 2025 Earnings
Apr 28, 2025 04:30PM Trident Filed 2024 Annual Report on Form 20-F
Apr 28, 2025 04:30PM Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Apr 28, 2025 04:30PM Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to Follow
Apr 28, 2025 04:30PM Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting
Apr 28, 2025 04:30PM Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
Apr 28, 2025 04:30PM Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting
Apr 28, 2025 04:30PM Macerich Declares the Quarterly Dividend on Its Common Shares
Apr 28, 2025 04:30PM Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
Apr 28, 2025 04:30PM SAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024
Apr 28, 2025 04:30PM Phoenix Asia Holdings Limited Announces Closing of Its Initial Public Offering
Apr 28, 2025 04:30PM Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance
Apr 28, 2025 04:30PM Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
Apr 28, 2025 04:30PM ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer
Apr 28, 2025 04:30PM CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
Apr 28, 2025 04:30PM iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates
View Newer Stories View Older Stories